BAM
FLGT icon

Belpointe Asset Management’s Fulgent Genetics FLGT Stock Holding History

Belpointe Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-99
Closed -$3.09K – 1527
2023
Q1 		$3.09K Buy
+99
New +$3.19K ﹤0.01% 3183

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Belpointe Asset Management's FLGT Position: Q2 2023 in Review

Belpointe Asset Management sold out of Fulgent Genetics (FLGT) in Q2 2023, closing a stake of 99 shares — an estimated $3.09K sold.

Belpointe Asset Management first reported a position in FLGT in Q1 2023 and held it in 1 quarter. The position peaked at $3.09K in Q1 2023. 214 funds tracked by Wall St. Rank hold FLGT as of Q2 2023.

  • Belpointe Asset Management reported no remaining Fulgent Genetics position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 99 Fulgent Genetics shares in Q2 2023, an estimated $3.09K.
  • Belpointe Asset Management first reported a position in Fulgent Genetics in Q1 2023 and held it in 1 quarter.
  • Belpointe Asset Management's Fulgent Genetics position peaked at $3.09K in Q1 2023.
  • 214 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.